Since the therapeutic cells of ACT are derived from autologous tumor-reactive TILs, it’s interesting to examine whether the progenitor exhausted Tcf1+Tim3-CD8+ T cells can be reprogrammed towards a memory-like phenotype through targeting lipid metabolism and/or mitochondrial fitness (Figure 2). The gene discussed is CD8A; the disease is neoplasm.